Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROSTATE-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 5798 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, HM; Wang, H; Zhang, W; Fuller, GN
      Tissue microarrays: Applications in neuropathology research, diagnosis, and education

      BRAIN PATHOLOGY
    2. Taneja, SS; Ha, S; Garabedian, MJ
      Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression

      JOURNAL OF CELLULAR BIOCHEMISTRY
    3. Heflin, MT; Cohen, HJ
      Cancer screening in the elderly

      HOSPITAL PRACTICE
    4. Craven, RA; Banks, RE
      Laser capture microdissection and proteomics: Possibilities and limitation

      PROTEOMICS
    5. Leibovici, D; Zisman, A; Siegel, YI; Lindner, A
      Cryosurgical ablation for prostate cancer: Preliminary results of a new advanced technique

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    6. Mullerad, M; Falik, T; Madeb, R; Nativ, O
      Hereditary prostate cancer - the search for the gene

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    7. Matzkin, H
      Freezing the prostate

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    8. Liu, HL; Gandour-Edwards, R; Lara, PN; White, RD; LaSalle, JM
      Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization

      CANCER JOURNAL
    9. Merrick, GS; Butler, WM; Galbreath, RW; Lief, JH; Adamovich, E
      Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy

      CANCER JOURNAL
    10. Sundararajan, V; Grann, VR; Jacobson, JS; Ahsan, H; Neugut, AI
      Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study

      CANCER JOURNAL
    11. Metz, JM; Jones, H; Devine, P; Hahn, S; Glatstein, E
      Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest

      CANCER JOURNAL
    12. Rimm, DL; Camp, RL; Charette, LA; Costa, J; Olsen, DA; Reiss, M
      Tissue microarray: A new technology for amplification of tissue resources

      CANCER JOURNAL
    13. Gillespie, JW; Ahram, M; Best, CJM; Swalwell, JI; Krizman, DB; Petricoin, EF; Liotta, LA; Emmert-Buck, MR
      The role of tissue microdissection in cancer research

      CANCER JOURNAL
    14. DeVita, VT; Bleickardt, EW
      National Oncology Forum: Perspectives for the year 2000

      CANCER JOURNAL
    15. Garderet, L; Cao, H; Salamero, J; Verge, V; Tisserand, E; Scholl, S; Gorin, NC; Lopez, M
      In vitro production of dendritic cells from human blood monocytes for therapeutic use

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    16. Griffith, TS; Broghammer, EL
      Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

      MOLECULAR THERAPY
    17. Singh, S; Cunningham, C; Buchanan, A; Jolly, DJ; Nemunaitis, J
      Toxicity assessment of intratumoral injection of the herpes simplex type Ithymidine kinase gene delivered by retrovirus in patients with refractory cancer

      MOLECULAR THERAPY
    18. Chhikara, M; Huang, HX; Vlachaki, MT; Zhu, XH; Teh, B; Chiu, KJ; Woo, S; Berner, B; Smith, EO; Oberg, KC; Aguilar, LK; Thompson, TC; Butler, EB; Aguilar-Cordova, E
      Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer

      MOLECULAR THERAPY
    19. Zisman, A; Ng, CP; Pantuck, AJ; Bonavida, B; Belldegrun, AS
      Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis

      JOURNAL OF IMMUNOTHERAPY
    20. Grossmann, ME; Davila, E; Celis, E
      Avoiding tolerance against prostatic antigens with subdominant peptide epitopes

      JOURNAL OF IMMUNOTHERAPY
    21. Schwaab, T; Lewis, LD; Cole, BF; Deo, Y; Fanger, MW; Wallace, P; Guyre, PM; Kaufman, PA; Heaney, JA; Schned, AR; Harris, RD; Ernstoff, MS
      Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI Xanti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu

      JOURNAL OF IMMUNOTHERAPY
    22. Galloway, RL
      The process and development of image-guided procedures

      ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
    23. Srivastava, RK
      TRAIL/Apo-2L: Mechanisms and clinical applications in cancer

      NEOPLASIA
    24. Jorgensen, TJ; Katz, S; Wittmack, EK; Varghese, S; Todo, T; Rabkin, SD; Martuza, RL
      Ionizing radiation does not alter the antitumor activity of herpes simplexvirus vector G207 in subcutaneous tumor models of human and murine prostate cancer

      NEOPLASIA
    25. Liu, XS; Shi, Y; Han, EKH; Chen, ZH; Rosenberg, SH; Giranda, VL; Luo, Y; Ng, SC
      Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells

      NEOPLASIA
    26. Udart, M; Utikal, J; Krahn, GM; Peter, RU
      Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of theepidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases

      NEOPLASIA
    27. Macoska, JA; Xu, JL; Ziemnicka, D; Schwab, TS; Rubin, MA; Kotula, L
      Loss of expression of human spectrin src homology domain binding protein 1is associated with 10p loss in human prostatic adenocarcinoma

      NEOPLASIA
    28. Bhujwalla, ZM; Artemov, D; Natarajan, K; Ackerstaff, E; Solaiyappan, M
      Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts

      NEOPLASIA
    29. Kim, SJ; Uehara, H; Karashima, T; Mccarty, M; Shih, N; Fidler, IJ
      Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

      NEOPLASIA
    30. Sporn, MB; Suh, N; Mangelsdorf, DJ
      Prospects for prevention and treatment of cancer with selective PPAR gammamodulators (SPARMs)

      TRENDS IN MOLECULAR MEDICINE
    31. Okada, S; Kopchick, JJ
      Biological effects of growth hormone and its antagonist

      TRENDS IN MOLECULAR MEDICINE
    32. Gendler, SJ; Mukherjee, P
      Spontaneous adenocarcinoma mouse models for immunotherapy

      TRENDS IN MOLECULAR MEDICINE
    33. Zogakis, TG; Libutti, SK
      General aspects of anti-angiogenesis and cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    34. Chen, RY; Kim, O; Li, M; Xiong, XS; Guan, JL; Kung, HJ; Chen, HG; Shimizu, Y; Qiu, Y
      Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain

      NATURE CELL BIOLOGY
    35. Scanlan, MJ; Jager, D
      Challenges to the development of antigen-specific breast cancer vaccines

      BREAST CANCER RESEARCH
    36. Finne, P; Finne, R; Stenman, UH
      Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques

      BJU INTERNATIONAL
    37. Shah, J; Mackay, S; Vale, J; Darzi, A
      Simulation in urology - a role for virtual reality?

      BJU INTERNATIONAL
    38. Madeja, Z; Miekus, K; Sroka, J; Djamgoz, MBA; Korohoda, W
      Homotypic cell-cell contacts stimulate the motile activity of rat prostatecancer cells

      BJU INTERNATIONAL
    39. Ferrero-Pous, M; Hersant, AM; Pecking, A; Bresard-Leroy, M; Pichon, MF
      Serum chromogranin-A in advanced prostate cancer

      BJU INTERNATIONAL
    40. Eaton, VS; Blackmore, TK
      Nilutamide-induced neutropenia

      BJU INTERNATIONAL
    41. Edwards, J; Krishna, NS; Mukherjee, R; Watters, AD; Underwood, MA; Bartlett, JMS
      Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer

      BJU INTERNATIONAL
    42. Chen, WC; Wu, HC; Lin, WC; Wu, MC; Hsu, CD; Tsai, FJ
      The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men

      BJU INTERNATIONAL
    43. Melchior, SW; Noteboom, J; Gillitzer, R; Lange, PH; Blumenstein, BA; Vessella, RL
      The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy

      BJU INTERNATIONAL
    44. Wymenga, LFA; Boomsma, JHB; Groenier, K; Piers, DA; Mensink, HJA
      Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase

      BJU INTERNATIONAL
    45. Wymenga, LFA; Gronier, K; Schuurman, J; Boomsma, JHB; Elferink, RO; Mensink, HJA
      Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis

      BJU INTERNATIONAL
    46. Kawanishi, Y; Lee, KS; Kimura, K; Kojima, K; Yamamoto, A; Numata, A
      Effect of radical retropubic prostatectomy on erectile function, evaluatedbefore and after surgery using colour Doppler ultrasonography and nocturnal penile tumescence monitoring

      BJU INTERNATIONAL
    47. Sells, H; Cox, R
      Undiagnosed macroscopic haematuria revisited: a follow-up of 146 patients

      BJU INTERNATIONAL
    48. Hara, I; Miyake, H; Hara, S; Yamanaka, N; Ono, Y; Eto, H; Takechi, Y; Arakawa, S; Kamidono, S
      Value of the serum prostate-specific antigen-alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer

      BJU INTERNATIONAL
    49. Baltaci, S; Orhan, D; Gogus, C; Turkolmez, K; Tulunay, O; Gogus, O
      Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma

      BJU INTERNATIONAL
    50. Haggstrom, S; Stattin, P; Wikstrom, P; Bergh, A; Damber, JE
      Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer

      BJU INTERNATIONAL
    51. Hamdy, FC; Thomas, BG
      New therapeutic concepts in prostate cancer

      BJU INTERNATIONAL
    52. Mucci, LA; Tamimi, R; Lagiou, P; Trichopoulou, A; Benetou, V; Spanos, E; Trichopoulos, D
      Are dietary influences on the risk of prostate cancer mediated through theinsulin-like growth factor system?

      BJU INTERNATIONAL
    53. Post, PN; Hansen, BE; Kil, PJM; Janssen-Heijnen, MLG; Coebergh, JWW
      The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study

      BJU INTERNATIONAL
    54. Parker, CC; Gospodarowicz, M; Warde, P
      Does age influence the behaviour of localized prostate cancer?

      BJU INTERNATIONAL
    55. Hruby, G; Choo, R; Klotz, L; Danjoux, C; Murphy, J; Deboer, G; Morton, G; Rakovitch, E; Szumacher, E; Fleshner, N
      The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer

      BJU INTERNATIONAL
    56. Ahman, AK; Jonsson, BA; Damber, JE; Bergh, A; Gronberg, H
      Low frequency of microsatellite instability in hereditary prostate cancer

      BJU INTERNATIONAL
    57. Koizumi, M; Yonese, J; Fukui, I; Ogata, E
      The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

      BJU INTERNATIONAL
    58. Feldman-Stewart, D; Brundage, MD; Nickel, JC; Mackillop, WJ
      The information required by patients with early-stage prostate cancer in choosing their treatment

      BJU INTERNATIONAL
    59. May, F; Treumann, T; Dettmar, P; Hartung, R; Breul, J
      Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer

      BJU INTERNATIONAL
    60. Stapleton, AMF; Cuncins-Hearn, A; Pinnock, C
      Attitudes to evidence-based practice in urology: Results of a survey

      ANZ journal of surgery
    61. Ollanketo, M; Hartonen, K; Riekkola, ML; Holm, Y; Hiltunen, R
      Supercritical carbon dioxide extraction of lycopene in tomato skins

      EUROPEAN FOOD RESEARCH AND TECHNOLOGY
    62. Tello, FL; Prats, CH; Gonzalez, MDD
      Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    63. Chavez, B; Mendez, JP; Ulloa-Aguirre, A; Larrea, F; Vilchis, F
      Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome

      JOURNAL OF HUMAN GENETICS
    64. Niopas, I; Daftsios, AC
      Determination of 2-hydroxyflutamide in human plasma by high-performance liquid chromatography and its application to pharmacokinetic studies

      JOURNAL OF CHROMATOGRAPHY B
    65. Boersma, BJ; Barnes, S; Kirk, M; Wang, CC; Smith, M; Kim, H; Xu, J; Patel, R; Darley-Usmar, VM
      Soy isoflavonoids and cancer - metabolism at the target site

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    66. Bello-DeOcampo, D; Kleinman, HK; Webber, MM
      The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinarmorphogenesis of human prostatic epithelial cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    67. Steinkellner, H; Rabot, S; Freywald, C; Nobis, E; Chabicovskyk, M; Knasmuller, S; Kassie, F
      Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    68. Weber, WW
      The legacy of pharmacogenetics and potential applications

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    69. Ames, BN
      DNA damage from micronutrient deficiencies is likely to be a major cause of cancer

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    70. Hemminki, K; Mutanen, P
      Genetic epidemiology of multistage carcinogenesis

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    71. Quader, STA; Bello-DeOcampo, D; Williams, DE; Kleinman, HK; Webber, MM
      Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    72. Sharp, RM; Bello-DeOcampo, D; Quader, STA; Webber, MM
      N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    73. El-Zein, R; Bondy, ML; Wang, LE; de Andrade, M; Sigurdson, AJ; Bruner, JM; Kyritsis, AP; Levin, VA; Wei, QY
      Risk assessment for developing gliomas: a comparison of two cytogenetic approaches

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    74. Kehr, J
      High resolution spatial analysis of plant systems

      CURRENT OPINION IN PLANT BIOLOGY
    75. Jin, Y; Tipoe, GL; Liong, EC; Lau, TYH; Fung, PCW; Leung, KM
      Overexpression of BMP-2/4,-5 and BMPR-IA associated with malignancy of oral epithelium

      ORAL ONCOLOGY
    76. Benoit, RM; Gronberg, H; Naslund, MJ
      A quantitative analysis of the costs and benefits of prostate cancer screening

      PROSTATE CANCER AND PROSTATIC DISEASES
    77. Tozawa, K; Akita, H; Kawai, N; Okamura, T; Sasaki, S; Hayashi, Y; Kohri, K
      KAI1 expression can be a predictor of stage A prostate cancer progression

      PROSTATE CANCER AND PROSTATIC DISEASES
    78. Soulie, M; Grosclaude, P; Villers, A; Menegoz, F; Schaffer, P; Mace-Lesec'h, J; Molinier, L; Sauvage-Machelard, M
      A population-based study on management of prostate cancer in four regions of France

      PROSTATE CANCER AND PROSTATIC DISEASES
    79. Peters, JL; Fairney, A; Kyd, P; Patel, A; Rogers, S; Webster, JJ; Vale, JA; Witherow, RON
      Bone loss associated with the use of LHRH agonists in prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    80. Chodak, GW; Kolvenbag, GJCM
      Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    81. Liu, YQ; Kyle, E; Patel, S; Housseau, F; Hakim, F; Lieberman, R; Pins, M; Blagosklonny, MV; Bergan, RC
      Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

      PROSTATE CANCER AND PROSTATIC DISEASES
    82. Slater, MD; Delprado, WJ; Murphy, CR; Barden, JA
      Detection of preneoplasia in histologically normal prostate biopsies

      PROSTATE CANCER AND PROSTATIC DISEASES
    83. Green, JSA; Knight, RJ; Hunter-Campbell, P; St George, DP; Walker, T; Wilson, C; Jarmulowicz, M; Kaisary, AV
      An investigation into the spatial relationship between prostate intraepithelial neoplasia and cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    84. Mydlo, JH; Tieng, NL; Volpe, MA; Chaiken, R; Kral, JG
      A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate

      PROSTATE CANCER AND PROSTATIC DISEASES
    85. Schasfoort, EMC; van de Beek, C; Newling, DWW
      Safety and efficacy of a nonsteroidal anti-androgen, based on results of apost marketing surveillance of nilutamide

      PROSTATE CANCER AND PROSTATIC DISEASES
    86. Soulie, M; Villers, A; Grosclaude, P; Menegoz, F; Schaffer, P; Mace-Lesec'h, J; Sauvage-Machelard, M; Grand, A
      A population-based study on radical prostatectomy in France

      PROSTATE CANCER AND PROSTATIC DISEASES
    87. Meng, MV; Carroll, PR
      Local therapy for prostate-specific antigen recurrence after definitive treatment

      PROSTATE CANCER AND PROSTATIC DISEASES
    88. McEleny, KR; Watson, RWG; Fitzpatrick, JM
      Defining a role for the inhibitors of apoptosis proteins in prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    89. Nasu, Y; Bangma, CH; Hull, GW; Yang, G; Wang, J; Shimura, S; McCurdy, MA; Ebara, S; Lee, HM; Timme, TL; Thompson, TC
      Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    90. Wu, JM; DiPietrantonio, AM; Hsieh, TC
      Mechanism of fenretinide (4-HPR)-induced cell death

      APOPTOSIS
    91. Matsuura, N; Kamae, I; Nakamura, H; Maruo, T
      Utility and treatment decisions: 15 clinical cases in Japan

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    92. Barton, MB; Dawson, R; Jacob, S; Currow, D; Stevens, G; Morgan, G
      Palliative radiotherapy of bone metastases: an evaluation of outcome measures

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    93. Panz, VR; Joffe, BI; Spitz, I; Lindenberg, T; Farkas, A; Haffejee, M
      Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men

      ENDOCRINE
    94. Mitsiades, CS; Koutsilieris, M
      Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    95. Limonta, P; Marelli, MM; Moretti, RM
      LHRH analogues as anticancer agents: pituitary and extrapituitary sites ofaction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    96. Gambineri, A; Pelusi, C; Vicennati, V; Pagotto, U; Pasquali, R
      Testosterone in ageing men

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    97. Harris, KA; Small, EJ
      Hormonal treatment for prostate cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    98. Holmes, EH
      PSMA specific antibodies and their diagnostic and therapeutic use

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    99. Goluboff, ET
      Exisulind, a selective apoptotic antineoplastic drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    100. Smith, HJ; Nicholls, PJ; Simons, C; Le Lain, R
      Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

      EXPERT OPINION ON THERAPEUTIC PATENTS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 05:43:24